F2G Ltd Announces the Appointment of Michael R. Hodges, M.D. to the Board of Directors
14-Sep-2010 -
F2G Limited announced the appointment of Dr Michael R. Hodges to the Company’s Board of Directors.
Michael R Hodges, M.D., BSc., MRCP (UK) has 20 years of biopharmaceutical development experience and has worked in both biotechnology and large pharmaceutical companies. Whilst at Pfizer Inc. Dr. ...
biotechnology
clinical trials
internal medicine